| Mean (SD) or N (%) |
---|---|
Female | 781 (71.0%) |
Age (years) | 57.1 (10.6) |
Education (years) | 12.3 (3.5) |
Smoking status | |
 Never | 666 (60.5%) |
 Former | 255 (23.2%) |
 Current | 179 (16.3%) |
Alcohol consumption (drinks/week) | 0.66 (2.6) |
BMI (kg/m2) | 31.20 (6.6) |
Type 2 diabetes | 216 (19.6%) |
Anti-hypertensive medication use | 649 (59.0%) |
Hypertension | 771 (70.1%) |
Epigenetic age acceleration | |
 IEAA (years) (N = 1099) | 0.15 (4.8) |
 EEAA (years) | 0.27 (5.9) |
 PhenoAA (years) (N = 1099) | 0.38 (7.2) |
 GrimAA (years) (N = 1099) | 0.11 (5.0) |
Cardiometabolic parameters | |
 Systolic blood pressure (mmHg) | 133.8 (21.6) |
 Diastolic blood pressure (mmHg) | 77.7 (11.9) |
 Mean arterial pulse pressure (mmHg) | 96.4 (13.5) |
 Pulse pressure (mmHg) | 56.2 (17.7) |
 Glucose (mg/dl) (N = 883) | 109.2 (42.1) |
 Insulin (mIU/l) (N = 882) | 11.5 (13.4) |
 Total cholesterol (mg/dl) (N = 1098) | 204.3 (45.2) |
 HDL-C (mg/dl) | 55.2 (17.9) |
 LDL-C (mg/dl) (N = 1076) | 120.8 (41.5) |
 Triglycerides (mg/dl) (N = 1099) | 146.0 (82.1) |
CVD 10-year risk scores | |
 Framingham risk score (%) (N = 945) | 14.4 (12.7) |
 ASCVD risk equation (%) (N = 988) | 11.6 (11.1) |
Prevalent CVD at baseline | 91 (8.3%) |
Incident CVD at follow-up | 72 (8.8 per 1000 person-years) |